Imatinib Mesylate Tablets, 400 mg
ARL/CT/13/001
Phase 3 small_molecule completed
Quick answer
Imatinib Mesylate Tablets, 400 mg for Chronic Myeloid Leukemia is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Chronic Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed